Lim Seok-Byung, Choi Hyo Seong, Jeong Seung-Yong, Kim Dae Yong, Jung Kyung Hae, Hong Yong Sang, Chang Hee Jin, Park Jae-Gahb
Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang-si, Korea.
Ann Surg. 2008 Aug;248(2):243-51. doi: 10.1097/SLA.0b013e31817fc2a0.
To evaluate the effect of the time interval between chemoradiotherapy (CRT) and surgery on CRT response and surgical outcomes.
Although preoperative CRT is a standard component of multimodal treatment for locally advanced rectal cancers, the optimal time for surgery after CRT has yet to be established. This study analyzed outcomes in 397 prospectively enrolled patients with locally advanced rectal cancer who underwent fractionated CRT involving 50.4 Gy radiotherapy followed by surgical resection between 4 and 8 weeks later.
Patients were divided into 2 groups according to the time that elapsed between CRT and surgery: group A (28-41 day interval) and group B (42-56 day interval). CRT responses and surgical outcomes were analyzed.
Of the 397 patients, 217 (54.7%) were in group A and 180 (45.3%) in group B. The 2 groups were similar in terms of pretreatment characteristics other than a slight difference in mean age (A: 55.3 years vs. B: 57.5 years, P = 0.042). Analysis of CRT responses showed that the 2 groups were similar in terms of T-level downstaging rate (A: 47.5% vs. B: 44.4%, P = 0.548), volume reduction rate (A: 34.6% vs. B: 34.2%, P = 0.870) and complete response rate (A: 13.8% vs. B: 15.0%, P = 0.740). Analysis of surgical outcomes showed that the 2 groups were also similar in terms of sphincter-preservation rate (A: 83.9% vs. B: 82.2%, P = 0.688) and anastomosis-related complication rate (A: 5.5% vs. B: 3.9%, P = 0.453). The median follow-up period was 31 months (range, 5-63), and both groups showed similar local recurrence-free survival rates (P = 0.1165).
The present findings suggest that compared with a 4 to 6 week interval, delaying surgery for 6 to 8 weeks after completion of fractionated radiotherapy with concurrent chemotherapy does not improve CRT response or the sphincter-preservation rate, and does not decrease morbidity or local recurrence.
评估放化疗(CRT)与手术之间的时间间隔对CRT反应和手术结果的影响。
尽管术前CRT是局部晚期直肠癌多模式治疗的标准组成部分,但CRT后手术的最佳时间尚未确定。本研究分析了397例前瞻性入组的局部晚期直肠癌患者的结局,这些患者接受了分次CRT,包括50.4 Gy放疗,随后在4至8周后进行手术切除。
根据CRT与手术之间的时间间隔将患者分为2组:A组(间隔28 - 41天)和B组(间隔42 - 56天)。分析CRT反应和手术结果。
397例患者中,217例(54.7%)在A组,180例(45.3%)在B组。两组在预处理特征方面相似,但平均年龄略有差异(A组:55.3岁 vs. B组:57.5岁,P = 0.042)。CRT反应分析显示,两组在T分期降期率(A组:47.5% vs. B组:44.4%,P = 0.548)、体积缩小率(A组:34.6% vs. B组:34.2%,P = 0.870)和完全缓解率(A组:13.8% vs. B组:15.0%,P = 0.740)方面相似。手术结果分析显示,两组在保肛率(A组:83.9% vs. B组:82.2%,P = 0.688)和吻合口相关并发症发生率(A组:5.5% vs. B组:3.9%,P = 0.453)方面也相似。中位随访期为31个月(范围5 - 63个月),两组的局部无复发生存率相似(P = 0.1165)。
目前的研究结果表明,与4至6周的间隔相比,在同步化疗的分次放疗完成后将手术推迟6至8周并不能改善CRT反应或保肛率,也不会降低发病率或局部复发率。